---
$id: https://graph.org.ai/products/commodity/51294404
$type: Product
source: UNSPSC
code: "51294404"
title: "Befuraline"
class: "51294400"
classTitle: "Antidepressant piperazines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Befuraline

**UNSPSC Code**: 51294404
**Class**: [Antidepressant piperazines](Antidepressant piperazines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 787AQ35GHR. European Medicines Agency schedules Befuraline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05683MIG. Befuraline generally arises in the molecular formula C20H20N2O2. The term BEFURALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) BEFURALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule befuraline under HS 29349990 and SITC 51579. As of Q4 2014, BEFURALINE remains the US FDA Preferred Term for this commodity. Befuraline bears US NLM identifiers UMLS ID C0053072 and NCI Concept Code C72720. SMILES: o1c(C(=O)N2CCN(CC2)Cc2ccccc2)cc2c1cccc2.

